Electrolytes supplementation can decrease the risk of nephrotoxicity in patients with solid tumors undergoing chemotherapy with cisplatin

• Päätekijät: Omary M. S. Minzi (Tekijä), Tatu E. Lyimo (Tekijä), Francis F. Furia (Tekijä), Alphonce I. Marealle (Tekijä), Manase Kilonzi (Tekijä), George M. Bwire (Tekijä), Christina Malichewe (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2020-09-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background Cisplatin is an important drug in the treatment of various Cancers. However, this drug causes nephrotoxicity that is linked to electrolyte derangement. The aim of this study was to evaluate the effect of electrolyte supplementation in reducing kidney injury in patients receiving...